| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.054 | 0.8 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.016 | 0.8 |